OVERVIEW

Recognizing and Appropriately Managing Pseudobulbar Affect in the Nursing Home Setting is organized by National Association for Continuing Education (NACE).

Start Date: 06/17/2019
Expiration Date: 06/17/2020

Target Audience:
Physicians, Nurse Practitioners and Physician Assistants that care for patients in nursing homes and long-term care settings

Credit(s):
• 1.0 AMA PRA Category 1 Credit™
• 1.0 AANP Contact hour which includes 0.50 pharmacology hours

Estimated Time To Complete CME Activity: 1.0 hour

Summary:
PBA may occur in association with a variety of neurological diseases, with prevalence rates ranging from 5% to over 50%, depending on diagnostic criteria, methodologies, and patient populations studied. Among nursing home residents, a recent survey found that PBA symptoms were present in 17.5% of residents with neurological conditions, and 9.0% of residents overall. A systematic review and meta-analysis of published literature documented PBA in approximately 1 in 5 stroke survivors at the acute and post-acute phases, and 1 in 8 survivors beyond 6 months post-stroke. This activity will examine the strategies for diagnosis of PBA, review the therapeutic options, and special considerations for management of PBA in the nursing home setting.

Learning Objectives:
After completing this program participants should be able to:
• Describe the prevalence and impact of pseudobulbar affect (PBA) among nursing home residents
• Outline strategies for the identification of PBA in the nursing home
• Review therapeutic options for PBA
• Describe special considerations for the management of PBA among nursing home residents

Additional details will be posted as soon as information is available.